Divergent Technologies Raises $160M to 3D-Print Car Parts
Courtesy of Divergent Technologies.

Divergent Technologies Raises $160M to 3D-Print Car Parts

Divergent Technologies wants to radically change automotive manufacturing with 3D printing, smarter software and an entirely new approach to assembly. A new $160 million round of funding should help the Torrance-based startup on that mission.


Divergent unveiled the Series C round on Monday, announcing investors like businessman (and 2020 Democratic presidential candidate) Tom Steyer and former Goldman Sachs president John L. Thornton, who has joined the company’s board of directors (Thornton also currently sits on Ford Motor Co.’s board). Bloomberg reported that London-based investment firm Hedosophia also participated in the round, which values Divergent at more than $1 billion and adds to $200 million in previous funding from the likes of Horizons Ventures and Altran Technologies.

The company’s technology combines generative design and 3D printing to create custom-tailored components for auto parts manufacturers. Its software inputs the volume of the part, where it needs to connect to the rest of the vehicle and what kind of loads it needs to tolerate. The computer then calculates the optimal shape and design for the final product; designs can be optimized for weight, strength, cost and other parameters. Once a design is selected, it’s constructed, layer by layer, by one of Divergent’s printers, and then assembled autonomously.

“It’s an entirely new production system that we've created from scratch,” Divergent senior vice president Lukas Czinger told dot.LA. “If your cost target changes, or your mass target changes, or your design volume changes, or you want to quickly introduce a variant to your car. Within days, literally, we can design, print and assemble that new design.”

Czinger was tight-lipped about which specific auto manufacturers the company is working with—but said Divergent would be making announcements this summer, and that three of the original equipment manufacturers (OEMs) it is working with “are within the five largest OEMs in the world.” Czinger confirmed that some of the car models that Divergent is designing for are electric vehicles.

In addition to making auto manufacturing cheaper and faster, Divergent also claims its system can reduce the industry’s carbon footprint by reducing waste and improving efficiency. Steyer—an environmentalist who made climate change a major part of his presidential campaign platform—said Divergent is “one of the companies I’m most hopeful will have an important impact on our ability to combat climate change” in a statement.

“Zero-emissions vehicles are an important part of a greener future, but if we can't reduce the environmental costs of building them in the first place, their impact will never be fully realized," Steyer said. “Divergent's technology can change that.”

Divergent said it will use the funding to scale up its manufacturing facilities, with plans for new factories in the U.S. and Europe “starting in 2024.”

Mars, Money, and Makeovers : LA’s Big Week

🔦 Spotlight

Happy Friday, LA!

This week has been full of energy in LA’s tech world, with some big moves that are hard to ignore. From a local company going public to bold partnerships and exciting projects, here’s a look at the stories driving conversations and shaping what’s happening right now.

Read moreShow less
🧬🔬AI-Driven Drug Discovery

🔦 Spotlight

Terray Therapeutics is at the forefront of AI-assisted drug discovery and development, operating a cutting-edge laboratory in Monrovia, California. The facility, roughly two-thirds the size of a football field, functions as a data powerhouse, generating over 50 terabytes of raw data daily, which is an amount of information equivalent to 12,000 high definition movies, through its miniaturized automation processes.

Terray Therapeutics exemplifies a new wave of innovative companies harnessing artificial intelligence to revolutionize drug discovery and development. The key to their approach lies in generating vast amounts of high-quality experimental data to train their AI systems. This data-driven strategy enables rapid experimentation and pattern recognition, allowing the AI to make informed predictions about potential treatments. Terray's generative AI can digitally design drug molecules, which are then synthesized and tested in their high-speed automated laboratory. The platform measures the interaction between these molecules and target proteins, with both successful and unsuccessful results feeding back into the AI system.

Read moreShow less
RELATEDTRENDING
LA TECH JOBS
interchangeLA